Table 2– Epidemiological characteristics of the selected studies
First author [ref.]CountryStudy designClinical settingStudy duration yr
Alffenaar [47]The NetherlandsOpen-label, prospective, pharmacokineticMonocentre, university medical centre2007–2008
Anger [34]USARetrospectiveMulticentre, public and private clinics2000–2006
De Lorenzo [35]ItalyRetrospectiveMonocentre, tuberculosis reference centre2009–2010
Fortún [22]SpainRetrospectiveMonocentre, Ramon y Cajal Hospital (Madrid, Spain)1999–2004
Nam [46]South KoreaRetrospectiveMonocentre, university medical centre2004–2007
Migliori [8]Belarus, Germany, Italy, SwitzerlandRetrospective, controlled, nonrandomised, unblindedMulticentre, 21 public hospitals and tuberculosis reference centres2001–2007
Park [45]South KoreaRetrospectiveMonocentre, university medical centre2003–2006
Schecter [30]USARetrospectiveMulticentre, public clinics2003–2007
Singla [31]IndiaProspectiveMonocentre, tertiary centre2006–2011
Udwadia [32]IndiaProspective, nonrandomisedMonocentre, private tertiary centre2000–2007
Villar [33]PortugalProspectiveMulticentre, public clinics2004–2009
von der Lippe [44]NorwayRetrospectiveMonocentre, university medical centre1998–2002